This is a problem that can happen after an organ transplant, like a lung, liver, or kidney. It occurs when the new organ doesn't work properly right away after being put in. It's often caused by damage to the organ's cells due to the stress of the surgery and the return of blood flow after a period of being without blood supply. This can sometimes lead to the body rejecting the new organ.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Primary graft dysfunction (PGD) is a serious problem in which a newly transplanted organ does not work well in the first hours or days after surgery. The "graft" is the transplanted organ itself. The word "primary" means the problem comes from injury to the organ during donation, storage and transplantation, not from rejection by the immune system, an infection or a surgical complication. The term is used most precisely for lung and heart transplants. After a lung transplant, PGD is a form of acute lung injury in the first 72 hours: fluid leaks into the new lungs, making it hard for them to move oxygen into the blood. After a heart transplant, it means the new heart pumps too weakly in the first 24 hours to support the body without strong heart medicines or a machine. In liver transplantation, a similar early problem ranges from a slow-starting liver (early allograft dysfunction) to one that never works (primary nonfunction). In kidney transplantation, the comparable problem is usually called delayed graft function, meaning dialysis is still needed in the first week. Because PGD appears so soon after surgery, it is recognized and treated in hospital, usually in intensive care. It ranges from mild and short-lived to life-threatening.
The central cause is ischemia-reperfusion injury. An organ is cut off from its blood supply (ischemia) while it is removed, preserved and transported. When blood flow returns in the recipient (reperfusion), the sudden return of oxygen and immune cells sets off inflammation that damages the organ's cells and small blood vessels. Stress on the organ before donation, such as the effects of the donor's brain death, can add to that injury. Risk depends on the donor, the recipient and the operation. For lung transplants, a large review found higher risk with older donors, donors who smoked, longer time without blood flow, use of a heart-lung bypass machine during surgery, and recipients with idiopathic pulmonary fibrosis, high blood pressure in the lungs (pulmonary hypertension) or a higher body weight. After heart transplant, older recipient age, diabetes, dependence on heart-support medicines before surgery and a long storage time for the donor heart are linked to higher risk. In liver transplantation, livers from "extended criteria" donors, such as livers with a lot of fat or from donation after circulatory death, carry more risk. These are associations that raise the odds, not causes anyone can be blamed for. Transplant teams weigh them when matching organs, because the alternative to an imperfect organ is often a long and risky wait.
The transplant team watches for PGD from the moment blood flow returns to the new organ. It is a diagnosis of exclusion: before calling a problem PGD, the team looks for other explanations such as rejection, infection, bleeding, a blocked blood vessel or another surgical problem, because those need different treatment. After a lung transplant, PGD is graded from 0 to 3 at set points over the first 72 hours. The grade combines a chest X-ray, which shows whether fluid is filling both lungs, with a blood test comparing how much oxygen reaches the blood to how much oxygen the person is breathing. The less oxygen gets through despite strong support, the higher the grade. Grade 3 at 48 or 72 hours is considered severe. After a heart transplant, the team uses heart ultrasound (echocardiography) and pressure measurements from catheters to see how well each side of the new heart pumps. PGD can affect the left side, the right side or both, and isolated right-side failure accounts for nearly half of cases. Its severity is judged largely by how much medicine or mechanical support the heart needs. After a liver transplant, blood tests over the first week, such as bilirubin, clotting (INR) and liver enzyme levels, show whether the new liver is starting to work.
There is no medicine that reverses PGD directly. Treatment supports the body and protects the new organ while it recovers from the injury, and it is adjusted hour by hour in intensive care. For the lungs, this means a breathing machine set to gentle pressures that avoid further injury, and careful limits on intravenous fluid so less fluid leaks into the lungs. Inhaled nitric oxide, a gas that relaxes blood vessels in the lungs, is sometimes used in severe cases, though it is not routinely recommended. When the lungs still cannot deliver enough oxygen, extracorporeal membrane oxygenation (ECMO) can take over. ECMO pumps blood through a machine outside the body that adds oxygen, giving the lungs time to heal. For the heart, the first step is medicines that strengthen the heartbeat (inotropes) and support blood pressure, along with steps to reduce strain on the right side of the heart. If these are not enough, a mechanical pump or ECMO can take over part of the circulation while the heart recovers. These devices can be lifesaving, but they bring real risks of bleeding, infection, blood clots and damage to blood cells, so the team aims to remove them as soon as the heart can manage. For a liver that is slow to start, supportive care is often enough. A liver that does not work at all (primary nonfunction) is a different situation: an urgent second transplant is the only effective treatment.
The course depends heavily on severity. PGD is an early, time-limited injury, and milder forms can settle as the organ recovers over the first days. In the heart, right-side dysfunction tends to peak within the first three days, and the typical recovery time in one series was about five days, though some people needed two weeks. Severe PGD often means a longer stay in intensive care, more time on a breathing machine or ECMO, and a slower rebuilding of strength afterward. PGD matters beyond the hospital stay. It is the most common cause of death in the early period after heart transplant. After lung transplant, severe PGD is linked to lower survival and to a higher chance of chronic lung allograft dysfunction (CLAD), a gradual, long-term loss of lung function in the transplanted lungs. That link does not mean CLAD is certain, but it is one reason teams follow lung function closely after a difficult start. Once someone leaves hospital, follow-up is the same intensive transplant care everyone receives: anti-rejection medicines, frequent clinic visits, blood tests and, after a lung transplant, regular breathing tests. For families, the early days can be frightening and uncertain. Asking the team for regular updates on what the support machines are doing and what signs of improvement they are watching for can make that period easier to follow.
PGD develops while a person is still in hospital under close monitoring, so there is no home warning sign for it. Before transplant, it is worth asking the team how they assess donor organs and what your own risk factors mean. During the hospital stay, ask for updates whenever the plan changes, such as starting ECMO or a mechanical pump. After discharge, later problems with a transplanted organ are not PGD and follow the warning signs your transplant team gives you. If PGD occurred, ask how it changes your follow-up plan.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Primary Graft Dysfunction is like, what's helped you, or ask the community a question.